Key Findings:  CBD is an inverse agonist for GPR3, GPR6, and GPR12 and as such may play a therapeutic role for conditions such as Alzheimer's disease, Parkinson's disease, cancer, and infertility for example.
Type of Study:  Laboratory Study
Study Result:  Positive
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Not Applicable
Chemotype:  Chemotype III